A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2011
10/12/2011	CN102215692A Improved turfgrass fungicide formulation with pigment
10/12/2011	CN102212596A Preparation method of human epidermal growth factor
10/12/2011	CN102212093A Flavonoid glycoside compounds, method for preparing same and application
10/12/2011	CN102212091A High-purity geniposide as well as preparation and clinical application of preparations thereof
10/12/2011	CN102212089A Novel alpha-amylase inhibitors (azatadine family compounds) and application thereof
10/12/2011	CN102212058A Single composite medicament (chiral nitrogenous heterocyclic ester) and synthesis method thereof as well as application of chiral nitrogenous heterocyclic ester in preparing low-toxicity CB1 receptor inhibitor
10/12/2011	CN102212008A Tanshinol ligustrazine derivative and preparation method and application thereof
10/12/2011	CN102210873A Application of C10orf116 genes in preparing medicament for improving insulin sensitivity of adipose tissue
10/12/2011	CN102210866A Oral preparation for slowing down absorption of alpha-glycosidase inhibitor and enhancing hypoglycemic drug effect
10/12/2011	CN102210865A Concomitant pharmaceutical agents and use thereof
10/12/2011	CN102210853A Method for preparing liposome containing EGFs (Epidermal Growth Factors) and transdermal short peptide fusion proteins, for controlling diabetic foot gangrene
10/12/2011	CN102210850A Method for increasing expression of deacetylase
10/12/2011	CN102210785A Method for extracting alpha-amylase inhibitor from Fuzhuan tea
10/12/2011	CN102210784A Composition preparation of vitamin E compounds and preparation method thereof
10/12/2011	CN102210747A Hypoglycemic pharmaceutical preparation and preparation method thereof
10/12/2011	CN102210741A Wall-breaking method for extraction of sophora flavescens
10/12/2011	CN102210739A Method for extracting total saponins and total flavonoids from alfalfa and preparation method thereof
10/12/2011	CN102210731A Soft capsule containing notoginseng adventitious root extract
10/12/2011	CN102210730A Medicinal composition containing pseudo-ginseng adventitious root extract
10/12/2011	CN102210724A Comprehensive use of ovateleaf holly bark medicinal material
10/12/2011	CN102210723A Method for preparing nano pills of black currant seed oil
10/12/2011	CN102210717A Compositions comprising Lactobacillus plantarum strains in combination with tannin and new Lactobacillus plantarum strains
10/12/2011	CN102210709A Manufacturing method of crocodile amour powder
10/12/2011	CN102210701A Application of hydrogen-saturated normal saline in preparation of medicine for treating hyperlipidemia disease
10/12/2011	CN102210666A Medical use of salvianolic acid A
10/12/2011	CN102210663A Diarylalkanes as potent inhibitors of binuclear enzymes
10/12/2011	CN102210659A Bifidobacterium microcapsule and preparing method thereof
10/12/2011	CN102210658A Microcapsule soft capsule preparation with high alpha-linolenic acid content
10/12/2011	CN101773512B 8-amino acid/11-vitamin containing micro granule capsule and preparation method thereof
10/12/2011	CN101375933B Process for the preparation of plant extracts for treating skin disorders and enhancing healing of wounds
10/12/2011	CN101337035B Traditional Chinese preparation with bacteriostatic action for preventing blood sugar rising and preparation method thereof
10/12/2011	CN101306169B Traditional Chinese medicine for treating cardiovascular and cerebrovascular disease
10/12/2011	CN101279993B 3-aryl-8-hydroxychromone-7-O-alpha-D-arabinofuranoside compound, synthetic method and use thereof
10/12/2011	CN101264158B Application of Chinese medicine composing prescription in preparing medicaments for treating metabolic syndrome
10/12/2011	CN101198326B Combined pharmaceutical preparation for treatment of type 2 diabetes
10/12/2011	CN101002765B Compressed formed preparation
10/11/2011	US8034799 Preventing and/or treating cardiovascular disease and/or associated heart failure
10/11/2011	US8034379 Hydrophilic gel foaming matrix; cellulose ethers
10/11/2011	CA2655395C Benzimidazole derivatives, method for the production thereof, their use as fxr agonists and pharmaceutical preparations containing the same
10/11/2011	CA2551909C Substituted azole derivatives, compositions, and methods of use
10/11/2011	CA2514191C Compound inhibiting dipeptidyl peptidase iv
10/11/2011	CA2494235C C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants
10/11/2011	CA2494100C Pyrazole compositions useful as inhibitors of gsk-3
10/11/2011	CA2488934C Aryl oxime derivatives as phosphodiesterase iv inhibitors for the treatment of diseases
10/11/2011	CA2472479C Deazapurines and uses thereof
10/11/2011	CA2457054C Activator of peroxisome proliferator-activated receptor .delta.
10/11/2011	CA2454665C Modifying the fatty acid composition of cell membranes of organs and tissues
10/11/2011	CA2442151C Stable solution of reduced coenzyme q
10/11/2011	CA2394862C Tnf-alpha antagonist and lfa-1 antagonist for treating lfa-1 or tnf-alpha mediated disorder
10/11/2011	CA2393410C Phosphonate compounds
10/11/2011	CA2363971C A method for producing preparations of mature and immature pancreatic endocrine cells, the cell preparation and its use for treatment of diabetes mellitus
10/11/2011	CA2341356C Poxvirus with targeted infection specificity
10/09/2011	CA2708905A1 A composition for treating diabetes and a process thereof
10/09/2011	CA2708901A1 A composition for treating hyperglycemia and a process thereof
10/06/2011	WO2011122879A2 Composition comprising coumestrol or a bean extract containing coumestrol
10/06/2011	WO2011122815A2 Novel quinoxaline derivatives
10/06/2011	WO2011122805A2 A composition comprising ajoene for preventing or treating a disease caused by overexpression of lxr-alpha
10/06/2011	WO2011122619A1 Phenylalanine derivative salt crystal
10/06/2011	WO2011122524A1 Controlled release pharmaceutical composition
10/06/2011	WO2011122523A1 Controlled release pharmaceutical composition
10/06/2011	WO2011122458A1 Aromatic ring compound containing nitrogen
10/06/2011	WO2011122389A1 Oil and fat composition for prevention or treatment of diabetes
10/06/2011	WO2011121496A1 Composition comprising insulin and herbal oil for transdermal or transmucosal administration
10/06/2011	WO2011121418A1 4 - aminopyrimidine derivatives and their as as adenosine a2a receptor antagonists
10/06/2011	WO2011121350A1 4 -amino -7,8- dihydropyrimido [5, 4 - f] [1, 4] oxazepin- 5 ( 6h) - one based dgat1 inhibitors
10/06/2011	WO2011121152A1 Chiral compounds and methods for obtaining and using same
10/06/2011	WO2011120923A1 Pharmaceutical composition comprising an sglt2 inhibitor and a ppar- gamma agonist and uses thereof
10/06/2011	WO2011120576A1 Antidiabetic enolic glucoside of phenylpyruvic acid
10/06/2011	WO2011120084A1 Transdermal delivery patch
10/06/2011	WO2011098262A3 P19arf, hmga2 and mdm2 for use in the diagnosis and treatment of aberrant cell growth
10/06/2011	WO2011081280A3 Novel glucokinase activators and processes for the preparation thereof
10/06/2011	WO2011053822A3 Notch inhibition in the treatment and prevention of obesity and metabolic syndrome
10/06/2011	WO2011035110A3 Treatment for oxidative stress and/or hypertension
10/06/2011	WO2010131035A8 Novel crystalline polymorph of sitagliptin dihydrogen phosphate
10/06/2011	WO2010074588A8 Pharmaceutical compounds
10/06/2011	WO2010047956A9 Azolopyrrolone melanin concentrating hormone receptor-1 antagonists
10/06/2011	US20110245348 Method of treating type I diabetes
10/06/2011	US20110245342 3,5,3'-triiodothyronine sulfate as thyromimetic agent and pharmaceutical formulations thereof
10/06/2011	US20110245340 Screening Method for Identifying Patients at Risk of Adverse Hepatologic Events
10/06/2011	US20110245322 Methods for identifying and compounds useful for increasing the functional activity and cell surface expression of cf-associated mutant cystic fibrosis transmembrane conductance regulator
10/06/2011	US20110245317 Use of organic compounds
10/06/2011	US20110245300 Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
10/06/2011	US20110245299 Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
10/06/2011	US20110245298 Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
10/06/2011	US20110245285 Process for preparation of rosuvastatin acetonide calcium
10/06/2011	US20110245282 Compounds
10/06/2011	US20110245269 Inhibitors of Advanced Glycation End Products
10/06/2011	US20110245267 Piperidine and piperazine derivatives and methods of use thereof
10/06/2011	US20110245263 2-heteroaryl-pyrrolo[3,4-c]pyrrole derivatives and their use as scd
10/06/2011	US20110245251 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
10/06/2011	US20110245250 Potassium ion channel modulators & uses thereof
10/06/2011	US20110245248 Isoquinoline derivatives
10/06/2011	US20110245245 Methods of treatment comprising the administration of heteroaryl compounds
10/06/2011	US20110245244 Phenoxy acetic acids as ppar delta activators
10/06/2011	US20110245233 Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the c-ring
10/06/2011	US20110245230 Pyrimidyl cyclopentanes as akt protein kinase inhibitors
10/06/2011	US20110245228 Protein kinase c activity enhancer containing alkyl ether derivative or salt thereof
10/06/2011	US20110245227 Pyridone gpr119 g protein-coupled receptor agonists
10/06/2011	US20110245225 Quinazolinamide derivatives
10/06/2011	US20110245223 Heterocyclic compounds

1 ... 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 ... 1298